Clicky

Agenus Inc.(AGEN) News

Date Title
Dec 26 Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
Dec 24 2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
Dec 21 GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
Dec 20 Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
Dec 13 Blueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Up
Dec 11 Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
Dec 7 Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study
Dec 7 Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS
Dec 6 Agenus (NASDAQ:AGEN) adds US$36m to market cap in the past 7 days, though investors from three years ago are still down 75%
Nov 30 Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised)
Nov 9 Rainbows and Unicorns: Agenus Inc. (NASDAQ:AGEN) Analysts Just Became A Lot More Optimistic
Nov 7 Agenus Inc (AGEN) Reports Q3 2023 Results: Revenue of $24.3 Million and Net Loss of $64.5 Million
Nov 7 Agenus Reports Third Quarter 2023 Results
Aug 24 Agenus (AGEN) to Focus on BOT/BAL Candidate, Stock Falls 7%
Aug 23 Watertown biotech shares spike after accidental data publication at Roche
Aug 23 Lexington biotech lays off 91 as it narrows focus
Aug 23 Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
Apr 26 Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting
Apr 25 Agenus to Provide Corporate Update and First Quarter 2023 Financial Report
Apr 24 Agenus to Participate in May Investor Conferences